Significant tachycardia, new or more frequent ectopy, or chest pain — notify the provider now and anticipate titrating down.
Before you read
Test yourself first: 2 questions
Question 1 of 2
A client in cardiogenic shock is prescribed dobutamine. The nurse understands the primary purpose of this drug is to:
Answer: A. Dobutamine is a beta-1 adrenergic agonist that increases myocardial contractility (positive inotropy), improving cardiac output in cardiogenic shock. It is not given to lower the heart rate, cause vasoconstriction primarily, or reduce contractility.
Question 2 of 2
The nurse is monitoring a client receiving IV dobutamine for acute decompensated heart failure. Which finding indicates a therapeutic response to this inotrope?
Answer: A. Dobutamine is a beta-1 agonist positive inotrope that increases myocardial contractility and cardiac output. A therapeutic response includes improved cardiac output reflected by warmer extremities, improved urine output, and decreased signs of congestion. Increasing crackles, falling urine output, and worsening peripheral cyanosis indicate inadequate cardiac output rather than improvement.
Keep the streak going with more questions like these, each with a full rationale.
What is dobutamine?
By stimulating beta-1 receptors in the heart muscle, it strengthens each contraction and raises cardiac output, which improves forward flow in low-output states. The cost is higher myocardial oxygen demand: heart rate can rise, and tachycardia, dysrhythmias, and chest pain may follow. Mild vasodilation can lower systemic vascular resistance and blood pressure, so volume status must be adequate. It is a high-alert drug, titrated by infusion pump with continuous ECG and blood pressure monitoring.
Key points to remember
- Mainly a beta-1 agonist: more contractility and cardiac output, fewer heart failure symptoms.
- Raises myocardial oxygen demand and can cause tachycardia, dysrhythmias, ectopy, and chest pain.
- Mild vasodilation can lower blood pressure; correct hypovolemia before relying on dobutamine.
- Given only as a titrated IV infusion by pump with continuous cardiac monitoring.
- Rising urine output is a sign the drug is working.
- Tolerance and reduced effect can develop with continuous infusions beyond about 72 hours.
- Incompatible with alkaline solutions such as sodium bicarbonate.
Nursing priorities
- Confirm adequate volume status before and during the infusion, because vasodilation can drop blood pressure in a volume-depleted client.
- Run the infusion on a pump through a patent IV, separate from sodium bicarbonate, because dosing must be precise and alkaline solutions are incompatible.
- Monitor ECG, heart rate, and blood pressure continuously and titrate to hemodynamic goals, because tachycardia and dysrhythmias can develop quickly.
- Assess response: lung sounds, urine output, peripheral perfusion, and daily weight, because these show whether cardiac output has improved.
- Report a sustained heart rate rise of more than about 10 percent above baseline or any new dysrhythmia, because the dose may need to be lowered.
Worked example
- Cue: A client with acute decompensated heart failure on a dobutamine infusion has a heart rate climbing well above baseline, frequent new ectopic beats, and chest pain.
- Meaning: The drug's increase in heart rate and oxygen demand is causing ischemia and irritability of the heart muscle.
- Action: Notify the provider now, anticipate titrating the dose down, and keep the client on continuous ECG monitoring.
- Evaluation: Heart rate returns toward baseline, ectopy and chest pain resolve, and urine output holds steady.
Patient teaching
- You will be on a heart monitor, and a pump controls how much medicine you get.
- Tell your nurse right away about chest pain, a racing or pounding heartbeat, or worse shortness of breath.
Common mistakes
- Expecting dobutamine to raise blood pressure. It strengthens contraction, and its mild vasodilation may lower blood pressure.
- Starting or increasing it in a client who is still hypovolemic.
- Judging success by blood pressure alone instead of urine output, lung sounds, and perfusion.
- Running it with sodium bicarbonate.
Red flags: report now
- Significant tachycardia, new or more frequent ectopy, or chest pain — notify the provider now and anticipate titrating down.
- Marked drop or rise in blood pressure — notify the provider.
- Urine output falling during the infusion — notify the provider, because perfusion is not improving.
- Sodium bicarbonate running in the same line — stop and separate the infusions.
References
Clinical references for this topic
